Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension
Treprostinil, a prostacyclin analogue, is approved for the treatment of pulmonary arterial hypertension (PAH) in adults. Transition from parenteral to oral treprostinil has been successfully accomplished in adults with PAH but not in children. In this multicenter study, pediatric patients treated wi...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Wiley
2019-07-01
|
| سلاسل: | Pulmonary Circulation |
| الوصول للمادة أونلاين: | https://doi.org/10.1177/2045894019856471 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|